AIRFLOW 50 INH

AIRFLOW 50 Inhaler

AIRFLOW 50 Inhaler is a high-quality bronchodilator formulation containing Salmeterol Xinafoate 50 mcg, designed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). It provides sustained bronchodilation and respiratory relief, helping patients breathe easier and live better.

Manufactured under GMP-certified standards, AIRFLOW 50 Inhaler ensures precise dosing, consistent aerosol delivery, and optimal pulmonary deposition for effective and dependable respiratory care.

Composition

• Active Ingredient: Salmeterol Xinafoate 50 mcg per actuation

• Dosage Form: Metered-dose inhaler (MDI) or dry powder inhaler (DPI), depending on product variant

• Excipients: Pharmaceutical-grade propellants and stabilizers (as applicable)

Key Indications

AIRFLOW 50 Inhaler is indicated for:

• Asthma:
  Long-term maintenance treatment of bronchospasm in patients with reversible obstructive airway disease, including those inadequately controlled on inhaled corticosteroids.

• Chronic Obstructive Pulmonary Disease (COPD):
  Maintenance treatment of airflow obstruction and reduction of symptoms such as breathlessness, cough, and wheezing.

Mechanism of Action

Salmeterol Xinafoate is a long-acting beta-2 adrenergic receptor agonist (LABA). It acts by stimulating beta-2 receptors in the bronchial smooth muscles, leading to muscle relaxation and bronchodilation.

• Prolonged Duration: Provides bronchodilation lasting up to 12 hours.

• Symptom Control: Reduces airway resistance, improves airflow, and decreases nighttime asthma symptoms.

• Preventive Action: Helps prevent exercise-induced bronchospasm and exacerbations in chronic airway diseases.

Dosage and Administration

• Recommended Dose for Adults and Adolescents (≥12 years):
  One inhalation (Salmeterol Xinafoate 50 mcg) twice daily — approximately 12 hours apart.

• For Children (4–12 years):
  As prescribed by the physician, depending on the condition and response.

• Administration:
  Inhale orally through the mouthpiece as directed. Shake well before use (for MDI).
  Rinse mouth after inhalation to minimize the risk of throat irritation.

Note: AIRFLOW 50 Inhaler is not intended for relief of acute bronchospasm. A fast-acting bronchodilator (rescue inhaler) should be used in such cases.

Key Benefits of AIRFLOW 50 Inhaler

• Long-Acting Relief: Provides up to 12 hours of sustained bronchodilation.

• Improved Lung Function: Reduces airway resistance and enhances airflow.

• Prevention of Symptoms: Effective in controlling wheezing, coughing, and breathlessness.

• Enhanced Quality of Life: Promotes better sleep, physical activity, and overall respiratory comfort.

• Reliable Dosing: Delivers consistent and accurate medication per actuation.

• Combination Therapy Ready: Compatible with inhaled corticosteroids for optimized asthma control.

Safety and Precautions

• Not for Acute Episodes: Should not be used for immediate relief of sudden asthma or COPD attacks.

• Corticosteroid Use: Continue inhaled or systemic corticosteroids as prescribed; do not discontinue abruptly.

• Cardiovascular Caution: Use with caution in patients with cardiovascular disorders, arrhythmias, or hypertension.

• Diabetes and Thyroid Disorders: Monitor patients closely, as beta-agonists may affect glucose or thyroid levels.

• Pregnancy and Lactation: Use only if potential benefits justify potential risks.

Possible Side Effects

Most patients tolerate AIRFLOW 50 Inhaler well. However, some may experience:

• Tremor or nervousness

• Headache

• Palpitations or mild tachycardia

• Throat irritation or hoarseness

• Muscle cramps

• Dizziness

If symptoms persist or worsen, discontinue use and consult a healthcare professional.

Storage Instructions

• Store below 30°C, protected from direct sunlight and moisture.

• Do not puncture or incinerate the canister.

• Keep out of reach of children.

Why Choose AIRFLOW 50 Inhaler?

AIRFLOW 50 Inhaler offers long-lasting respiratory control with reliable performance and proven efficacy. Designed for ease of use and consistent drug delivery, it supports better treatment adherence and symptom management in asthma and COPD patients.

With GMP-certified manufacturing and clinically validated effectiveness, AIRFLOW 50 Inhaler stands as a trusted choice for physicians and patients seeking dependable, long-term bronchodilation therapy.

Disclaimer

This product information is intended for educational and informational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider before starting or changing any medication.